Estrogen receptor beta inhibits 17beta-estradiol-stimulated proliferation of the breast cancer cell line T47D. - Wikidata - awgldk - TriplyDB

Estrogen receptor beta inhibits 17beta-estradiol-stimulated proliferation of the breast cancer cell line T47D.

Estrogen receptor beta inhibits 17beta-estradiol-stimulated proliferation of the breast cancer cell line T47D.

http://www.wikidata.org/entity/Q36160032

about

Drug and cell type-specific regulation of genes with different classes of estrogen receptor beta-selective agonists Induction of ErbB-3 expression by alpha6beta4 integrin contributes to tamoxifen resistance in ERbeta1-negative breast carcinomas Estrogen receptor beta-selective agonists stimulate calcium oscillations in human and mouse embryonic stem cell-derived neurons Regulation of specific target genes and biological responses by estrogen receptor subtype agonists Estrogen Receptors alpha and beta as determinants of gene expression: influence of ligand, dose, and chromatin binding Liquiritigenin is a plant-derived highly selective estrogen receptor beta agonist Estradiol downregulates miR-21 expression and increases miR-21 target gene expression in MCF-7 breast cancer cells Aberrant Splicing of Estrogen Receptor, HER2, and CD44 Genes in Breast Cancer The Effect of Menopausal Hormone Therapies on Breast Cancer: Avoiding the Risk Plant sterols as anticancer nutrients: evidence for their role in breast cancer Putative biomarkers and targets of estrogen receptor negative human breast cancer The p53-estrogen receptor loop in cancer Cyclopia extracts act as ERα antagonists and ERβ agonists, in vitro and in vivo Addressing the soy and breast cancer relationship: review, commentary, and workshop proceedings Similar in vitro maturation rates of oocytes retrieved during the follicular or luteal phase offer flexible options for urgent fertility preservation in breast cancer patients Phytoestrogens and breast cancer prevention: possible mechanisms of action Combined effects of MDM2 SNP309 and TP53 R72P polymorphisms, and soy isoflavones on breast cancer risk among Chinese women in Singapore Development of a recombinant human ovarian (BG1) cell line containing estrogen receptor α and β for improved detection of estrogenic/antiestrogenic chemicals Identification of estrogen receptor dimer selective ligands reveals growth-inhibitory effects on cells that co-express ERα and ERβ Crosstalk between steroid receptors and the c-Src-receptor tyrosine kinase pathways: implications for cell proliferation.The molecular basis of genistein-induced mitotic arrest and exit of self-renewal in embryonal carcinoma and primary cancer cell lines Biphenyl C-cyclopropylalkylamides: New scaffolds for targeting estrogen receptor beta Genome-wide dynamics of chromatin binding of estrogen receptors alpha and beta: mutual restriction and competitive site selection.Hes-6, an inhibitor of Hes-1, is regulated by 17beta-estradiol and promotes breast cancer cell proliferation Quantitative profiles of the mRNAs of ER-alpha and its novel variant ER-alpha36 in breast cancers and matched normal tissues.Negative regulation of estrogen signaling by ERβ and RIP140 in ovarian cancer cells.Estrogen receptor β induces antiinflammatory and antitumorigenic networks in colon cancer cells.Estrogen receptor beta functions through nongenomic mechanisms in lung cancer cells.Effect of estrogen receptor β agonists on proliferation and gene expression of ovarian cancer cells The potential health effects of dietary phytoestrogens Sex differences in estrogen receptor subcellular location and activity in lung adenocarcinoma cells Estrogen Receptor β as a Therapeutic Target in Breast Cancer Stem Cells.A vegetable-fruit-soy dietary pattern protects against breast cancer among postmenopausal Singapore Chinese women.New hypotheses and opportunities in endocrine therapy: amplification of oestrogen-induced apoptosis.Somatic loss of estrogen receptor beta and p53 synergize to induce breast tumorigenesis.In vitro effects of polyphenols on colorectal cancer cells.Oestrogen receptors β1 and βcx have divergent roles in breast cancer survival and lymph node metastasis.ERalpha-negative and triple negative breast cancer: molecular features and potential therapeutic approaches Estrogen receptor beta decreases survival of p53-defective cancer cells after DNA damage by impairing G₂/M checkpoint signaling.The molecular mechanisms underlying the pharmacological actions of ER modulators: implications for new drug discovery in breast cancer.

P2860

Q21091197-9760CC67-4E32-42A3-ADA3-6ABEACED6015 Q21144348-BF69FAD1-C3F3-4AA4-9EBE-271B57EBB201 Q21562188-3172EEBF-EF25-409F-B7E9-DD6F7995B65C Q24621003-B58318B2-BD1D-4676-A3B9-B31C43EC3A4C Q24647300-B2A9BCD6-2402-4F45-A311-F2B835BFA7E2 Q24647962-C5D6DE57-935A-415B-A433-B2BD107AD7DB Q24649539-143733CF-88B8-485E-8E33-BD7CF800242F Q26773907-E4A145E0-517F-45C9-9934-1F2EF23CC9BC Q26821782-ED1456D8-1480-4596-ABCE-C0517D5FB4C5 Q26861053-24B05EE4-1461-45DA-8F85-5C89C051CD1D Q27003285-93BDBAED-7006-4FEB-8F48-499D5154F83B Q27027865-68B42370-43C8-46D0-84A3-642A28D1FB7D Q27302901-BF16A48D-BFCD-4A78-955C-23F6B5415209 Q28264426-5ADDD301-7369-4716-BAF6-CF50E2F420C7 Q28271961-ADB934C5-7C03-4F41-A030-A6B3F84FEEDB Q28276620-9FB8FC24-11A5-4EE0-A73C-C6EB422E9ECE Q28386766-4BCED35F-381A-4651-A450-E2C100983B65 Q28388405-73CCD514-7E64-4055-B1F7-B71AE2B0FC00 Q28480546-F877DE80-16EC-4772-8D44-3697360D46B3 Q30434843-4769AD94-DBCB-4FC1-A7BA-93EF9E1BEBFB Q33375180-948A4836-17CB-42D9-AF50-47D511734218 Q33428431-F772DA88-4F3F-4F40-8F3B-5AD678C047B9 Q33576510-9708A443-F85D-49DE-8A08-8A5CF0D41C95 Q33627143-26173273-2AEC-4B63-9099-730C11673074 Q33629626-EE36524E-8A57-463C-B899-4321B50B1E32 Q33633056-CFD6CC8E-E06F-4C68-9573-CFB50560AFB9 Q33636941-C45E6489-22A6-4438-A548-1ADF345F11EE Q33638946-1C15826B-89E3-46BF-A552-5D02C618A529 Q33651509-BD4A1567-5C27-41A1-8632-3778E8005113 Q33676455-C9370316-82C5-47B9-9CB7-610700F253B1 Q33695898-CA65123F-926E-4787-BB90-5385A7AE39C8 Q33718203-5B4D6F92-CF28-4A92-AE88-242FDC9798E4 Q33750181-D9252F32-A551-4CEC-8E64-1AA00BC786C6 Q33841512-18B2D3C2-678A-4083-A334-28E57166C0E7 Q33864656-9B0043F8-E277-46AA-8FC1-38806E8A5EC8 Q34049121-F7191BDC-5F85-45DC-9A46-DCA8DE957B4D Q34113589-31FCFAEB-1A67-41DC-A970-C0BA16F90A10 Q34119028-370C31E9-6960-4E4D-8A21-47D1AA52EE9A Q34125558-3BF9BA83-D05D-45A0-8CED-0D629FF47A63 Q34311300-08F48874-B2EE-4BBA-8A24-D98B84BA3D4B

P2860

Estrogen receptor beta inhibits 17beta-estradiol-stimulated proliferation of the breast cancer cell line T47D.

http://www.wikidata.org/entity/Q36160032

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

2004年论文

@zh

2004年论文

@zh-cn

name

Estrogen receptor beta inhibit ...... breast cancer cell line T47D.

@ast

Estrogen receptor beta inhibit ...... breast cancer cell line T47D.

@en

type

label

Estrogen receptor beta inhibit ...... breast cancer cell line T47D.

@ast

Estrogen receptor beta inhibit ...... breast cancer cell line T47D.

@en

prefLabel

Estrogen receptor beta inhibit ...... breast cancer cell line T47D.

@ast

Estrogen receptor beta inhibit ...... breast cancer cell line T47D.

@en

P1433

Q36160032-973D3B7B-FDBF-47E6-9CF2-3B0AC0136315

P1476

Q36160032-A7CC5783-BD06-4FF1-9FE5-132432768C51

P2093

Q36160032-1C96511C-6E83-4E1F-AA89-E59B7314DB08

Q36160032-A6CC9768-AC2D-49D3-97E3-BB996E681A2D

Q36160032-C31637E7-ECDB-4B43-B578-4719E67D5124

Q36160032-D94D8427-8717-442F-B041-44795D293B6D

Q36160032-EEE72D4E-BB61-400D-B8FE-6E75F4C8A7EC

P2860

Q36160032-076B5F73-E497-4433-BBBD-019B40B448D8

Q36160032-1E503789-4DA9-4246-A134-4798581296A1

Q36160032-22EB78EA-C94D-42D4-8398-04AB38F8FFCF

Q36160032-2B3A0B7B-74C1-4601-82A9-5A2FCED78B98

Q36160032-2BE19AF3-05D6-4446-B098-93E96B83BC69

Q36160032-3A244176-B6A7-49AA-A306-865A9C61A229

Q36160032-3A5880F1-3F6F-4D3F-B140-0EE69BEADA4B

Q36160032-40CC675A-0B3B-4890-8DFB-BB9E057A197D

Q36160032-49377D93-F792-4CE7-8913-E643CE08DC84

Q36160032-4CF75642-4F4B-45E4-834F-7B152CAA2848

P304

Q36160032-CEB42612-EDA7-401C-B1D0-884B5EB33E9B

P31

Q36160032-6899B40D-3883-43EA-BF58-FB2CED0B0ED5

P356

Q36160032-40EFC2D1-C90F-4CA6-9A3D-CEB55DDD82C5

P407

Q36160032-9ED3D060-0196-4A79-82D8-CFE2986E6059

P433

Q36160032-5DE8CB15-8889-46DB-B852-4DA23477DDB4

P478

Q36160032-7B313D2D-5195-4EA7-A825-AFBD8AF5F039

P50

Q36160032-C0E9C2F9-ABF8-4C94-B2FE-AD079752AA87

P577

Q36160032-A2EA4430-5057-47B9-AE16-C8DEEA6CF80A

P5875

Q36160032-DD50523C-FA48-42F4-A748-0E0999756064

P698

Q36160032-0A4B078E-1FDC-44B4-95E6-586B3942A205

P932

Q36160032-782E5FFF-C689-4414-916F-292613B6597D

P356

PNAS.0308319100

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Estrogen receptor beta inhibit ...... breast cancer cell line T47D.

@en

P2093

Anders Ström

http://www.w3.org/2001/XMLSchema#string

James S Foster

http://www.w3.org/2001/XMLSchema#string

Jay Wimalasena

http://www.w3.org/2001/XMLSchema#string

Johan Hartman

http://www.w3.org/2001/XMLSchema#string

Silke Kietz

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular cloning and characterization of human estrogen receptor betacx: a potential inhibitor ofestrogen action in human

Oncogenic role of the ubiquitin ligase subunit Skp2 in human breast cancer

Estrogen receptor (ER) beta, a modulator of ERalpha in the uterus

Tamoxifen functions as a molecular agonist inducing cell cycle-associated genes in breast cancer cells

Constitutive overexpression of cyclin D1 but not cyclin E confers acute resistance to antiestrogens in T-47D breast cancer cells

The partial agonist activity of antagonist-occupied steroid receptors is controlled by a novel hinge domain-binding coactivator L7/SPA and the corepressors N-CoR or SMRT

Cyclin E ablation in the mouse

Cdk2 dethroned as master of S phase entry

Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites

Postmenopausal hormone replacement therapy: scientific review.

P304

1566-1571

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0308319100

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

101

http://www.w3.org/2001/XMLSchema#string

P50

Jan-Åke Gustafsson

P577

2004-01-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8901660

http://www.w3.org/2001/XMLSchema#string

P698

14745018

http://www.w3.org/2001/XMLSchema#string

P932

341775

http://www.w3.org/2001/XMLSchema#string